Trust in Science Africa
Trust in Science is a research funding programme designed to build a sustainable, long-term scientific research base in Africa, to deliver medicines that are specific to patient needs. Initially, it is open to scientists working in Kenya, Tanzania and Uganda
The wider aims of Trust in Science Africa are to:
- Drive sustainable investment in local scientific innovation and capabilities
- Help translate science into meaningful benefits for patients
- Deliver breakthrough science to address health issues for which there is currently no or little treatment
- Support GSK’s position as healthcare partner of choice for scientists, and establish relationships leading to further collaborations
- Share talent, technologies and scientific insight between GSK and selected research groups
We are committed to seeking out the best scientific ideas and funding their development, and are keen to receive applications from both young scientists and established research groups. Applications from all countries will be considered together, and the best applications overall – based on scientific merit - will be chosen for funding by an independent scientific advisory panel. The programme seeks to support scientific research that can rapidly translate into an improvement in the lives of patients. Research proposals related to locally relevant medical needs are especially encouraged.
Priority research areas
Successful proposals will identify areas of mutual interest, in which questions may be answered to deliver breakthroughs in the understanding of specific diseases. We already have substantial research and drug discovery efforts across several major therapeutic areas. Trust in Science is specifically seeking proposals from the following areas of research.
Respiratory and other non-communicable diseases
COPD, asthma: strategies to enhance access to treatment and guideline supported disease management
Cardiovascular disease (including hypertension, hyperlipidemia, MI, cardiac failure, stroke): strategies to enhance current understanding of disease epidemiology, population relevant genetic risk factors, factors influencing disease outcomes.
Diabetes, obesity, atherosclerosis, cardiac failure
Infectious diseases including TB and HIV
- New approaches for treating viral (including hepatitis C virus, hepatitus B virus, respiratory syncytial virus, human papilloma virus, HIV) and bacterial infection
- Initiatives that seek to develop clinical investigators based in health centres outside of primary centres of excellence
- Neonatal sepsis – initiatives that seek to improve the speed and accuracy of diagnosis and simplify treatment management
Neglected Tropical Diseases
Tropical diseases (malaria, Human African Trypanosomiasis, leishmaniasis)
Immunology and Inflammation
Epigenetics, rheumatoid arthritis, cytokines and chemokines in disease processes
Protein therapeutics including monoclonal antibodies
The programme is actively seeking projects in the areas listed above, however if you have an exceptional idea that has the potential to significantly improve patient health, you may submit the proposal together with a clear rationale explaining why it should be considered. Only those ideas that are exceptional will pass through the screening stage.
2014 award winners
|2014 Winners of Trust in Science call||Institution and country||Title of project|
|Dr David Kateete||Makarere University, Kampala, Uganda||Validation of mycobacterial rhomboid proteases as anti-TB drug/vaccine targets|
|Dr Clara Wekesa||MRC/UVRI Uganda Research Unit on AIDS, Uganda||Prevalence and risk factors for liver fibrosis among HIV-infected patients in rural Uganda|
|Dr Omalla Allan||Kenya Medical Research Institute (KEMRI), Kenya||In vitro screening of African tropical plant extracts as potential targets if chronic CD4 T-cell activation and the HIV-1 viral reservoir|
|Dr Bernhard Ogutu||Centre for Research in Therapeutic Sciences, Nairobi, Kenya||Pharmaco-epidemiology of hypertension therapeutics in selected Kenyan health facilities HT-AGT2|
|Dr Bruce Kirenga||Makarere University, Kampala, Uganda||The Uganda Registry for Asthma and COPD (URAC) Project|
|Dr Samuel Okurut||Makarere University, Kampala, Uganda||Phenotypic and Functional Characterization of B Cells in Cerebrospinal Fluid and Peripheral Blood of HIV-Associated Cryptococcal Meningitis|